Printer Friendly

Browse Bone disorder agents topic

Health aspects subtopic


1-16 out of 16 article(s)
Title Author Type Date Words
Effect of zoledronic acid infusion therapy in Paget's disease/Paget hastaligi tedavisinde zoledronik asit infuzyonunun etkisi. Akcay Yalbuzdag, Seniz; Celik, Canan Report Mar 1, 2014 2145
The anti-osteoporotic drug preferences of physiatrists: a multicenter descriptive study/Fiziatristlerin antiosteoporotik ilac tercihleri: cok merkezli tanimlayici arastirma. Kutsal, Yesim Gokce; Ozdemir, Oya; Caliskan, Asli; Inanici, Fatma; Karahan, Sevilay; Dogan, Asuman; Report Aug 1, 2012 3752
Atypical femoral fracture is a real risk--but a rarity--with long-term use of antiresorptive drugs. Goldstein, Steven R. Report Nov 1, 2011 620
Popular bone drugs may reduce your risk of colon cancer. Nov 1, 2011 700
Encouragement aids antiresorptive therapy adherence. Boschert, Sherry Report Oct 1, 2011 819
Aromatase inhibitors and bone health. Bundred, Nigel J. Clinical report Jul 1, 2010 4209
Lasofoxifene cuts fractures after menopause. Moon, Mary Ann Report Apr 15, 2010 788
Adjuvant zoledronic acid may aid breast ca survival. Jancin, Bruce Feb 1, 2009 767
Pfizer Inc. Report Sep 8, 2008 146
Unique medical Breakthroughs in the world of cancer. Jun 25, 2008 446
Unique medical Breakthroughs in the world of cancer. Jun 25, 2008 446
New Hope For Breast Cancer Patients. Jun 17, 2008 361
Zoledronic acid infusions cut treatment-related bone loss. Jancin, Bruce Mar 1, 2008 595
New weapons in the war on osteoporosis: a wide spectrum of drug therapies now give women with osteoporosis more options and better outcomes. Aug 1, 2007 1262
Bone-building drugs are not always forever. Etingin, Orli R. Cover story Jan 1, 2007 152
Bisphosphonate-associated osteonecrosis of the jaw: A literature review and clinical practice guidelines. Pickett, Frieda Atherton Report Jun 22, 2006 6537

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters